nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—Panic attack—Capecitabine—colon cancer	0.0432	0.0442	CcSEcCtD
Vilazodone—Night sweats—Capecitabine—colon cancer	0.0298	0.0305	CcSEcCtD
Vilazodone—Hyponatraemia—Vincristine—colon cancer	0.018	0.0184	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Capecitabine—colon cancer	0.0178	0.0182	CcSEcCtD
Vilazodone—Hyponatraemia—Irinotecan—colon cancer	0.0175	0.0179	CcSEcCtD
Vilazodone—Cataract—Capecitabine—colon cancer	0.0169	0.0173	CcSEcCtD
Vilazodone—Irritability—Fluorouracil—colon cancer	0.0159	0.0163	CcSEcCtD
Vilazodone—Dry eye—Capecitabine—colon cancer	0.0149	0.0152	CcSEcCtD
Vilazodone—Erectile dysfunction—Vincristine—colon cancer	0.0143	0.0146	CcSEcCtD
Vilazodone—Gastroenteritis—Capecitabine—colon cancer	0.0132	0.0135	CcSEcCtD
Vilazodone—Libido decreased—Capecitabine—colon cancer	0.0126	0.0129	CcSEcCtD
Vilazodone—Increased appetite—Capecitabine—colon cancer	0.0124	0.0127	CcSEcCtD
Vilazodone—Hallucination—Vincristine—colon cancer	0.0123	0.0126	CcSEcCtD
Vilazodone—Connective tissue disorder—Vincristine—colon cancer	0.0122	0.0125	CcSEcCtD
Vilazodone—Connective tissue disorder—Irinotecan—colon cancer	0.0119	0.0121	CcSEcCtD
Vilazodone—Hyponatraemia—Capecitabine—colon cancer	0.0117	0.012	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.0116	0.0118	CcSEcCtD
Vilazodone—Cardiac disorder—Vincristine—colon cancer	0.0115	0.0118	CcSEcCtD
Vilazodone—Migraine—Capecitabine—colon cancer	0.0115	0.0118	CcSEcCtD
Vilazodone—Aripiprazole—ABCB1—colon cancer	0.0112	0.501	CrCbGaD
Vilazodone—Cardiac disorder—Irinotecan—colon cancer	0.0112	0.0115	CcSEcCtD
Vilazodone—Trazodone—ABCB1—colon cancer	0.0112	0.499	CrCbGaD
Vilazodone—Irritability—Capecitabine—colon cancer	0.0111	0.0114	CcSEcCtD
Vilazodone—Mental disorder—Vincristine—colon cancer	0.0109	0.0111	CcSEcCtD
Vilazodone—Breast disorder—Capecitabine—colon cancer	0.0105	0.0108	CcSEcCtD
Vilazodone—Flatulence—Irinotecan—colon cancer	0.0103	0.0106	CcSEcCtD
Vilazodone—Agitation—Vincristine—colon cancer	0.00991	0.0101	CcSEcCtD
Vilazodone—Vision blurred—Fluorouracil—colon cancer	0.00948	0.0097	CcSEcCtD
Vilazodone—Convulsion—Vincristine—colon cancer	0.00934	0.00956	CcSEcCtD
Vilazodone—Convulsion—Fluorouracil—colon cancer	0.00871	0.00891	CcSEcCtD
Vilazodone—Nervous system disorder—Vincristine—colon cancer	0.00863	0.00883	CcSEcCtD
Vilazodone—Hyperhidrosis—Vincristine—colon cancer	0.00851	0.0087	CcSEcCtD
Vilazodone—Nervous system disorder—Irinotecan—colon cancer	0.00841	0.0086	CcSEcCtD
Vilazodone—Irritability—Methotrexate—colon cancer	0.00829	0.00848	CcSEcCtD
Vilazodone—Hyperhidrosis—Irinotecan—colon cancer	0.00829	0.00848	CcSEcCtD
Vilazodone—Nervous system disorder—Fluorouracil—colon cancer	0.00805	0.00823	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00802	0.0082	CcSEcCtD
Vilazodone—Insomnia—Vincristine—colon cancer	0.00796	0.00814	CcSEcCtD
Vilazodone—Connective tissue disorder—Capecitabine—colon cancer	0.00793	0.00812	CcSEcCtD
Vilazodone—Paraesthesia—Vincristine—colon cancer	0.0079	0.00808	CcSEcCtD
Vilazodone—Breast disorder—Methotrexate—colon cancer	0.00785	0.00803	CcSEcCtD
Vilazodone—Insomnia—Irinotecan—colon cancer	0.00775	0.00793	CcSEcCtD
Vilazodone—Paraesthesia—Irinotecan—colon cancer	0.0077	0.00787	CcSEcCtD
Vilazodone—Decreased appetite—Vincristine—colon cancer	0.00765	0.00783	CcSEcCtD
Vilazodone—Somnolence—Irinotecan—colon cancer	0.00762	0.00779	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Vincristine—colon cancer	0.0076	0.00777	CcSEcCtD
Vilazodone—Fatigue—Vincristine—colon cancer	0.00759	0.00776	CcSEcCtD
Vilazodone—Eye disorder—Capecitabine—colon cancer	0.00755	0.00772	CcSEcCtD
Vilazodone—Dyspepsia—Irinotecan—colon cancer	0.00754	0.00772	CcSEcCtD
Vilazodone—Cardiac disorder—Capecitabine—colon cancer	0.00749	0.00767	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00748	0.00765	CcSEcCtD
Vilazodone—Decreased appetite—Irinotecan—colon cancer	0.00745	0.00762	CcSEcCtD
Vilazodone—Insomnia—Fluorouracil—colon cancer	0.00742	0.00759	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Irinotecan—colon cancer	0.0074	0.00757	CcSEcCtD
Vilazodone—Fatigue—Irinotecan—colon cancer	0.00739	0.00756	CcSEcCtD
Vilazodone—Paraesthesia—Fluorouracil—colon cancer	0.00737	0.00754	CcSEcCtD
Vilazodone—Somnolence—Fluorouracil—colon cancer	0.0073	0.00747	CcSEcCtD
Vilazodone—Dyspepsia—Fluorouracil—colon cancer	0.00723	0.00739	CcSEcCtD
Vilazodone—Decreased appetite—Fluorouracil—colon cancer	0.00714	0.0073	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00709	0.00725	CcSEcCtD
Vilazodone—Mental disorder—Capecitabine—colon cancer	0.00707	0.00724	CcSEcCtD
Vilazodone—Feeling abnormal—Irinotecan—colon cancer	0.00706	0.00722	CcSEcCtD
Vilazodone—Malnutrition—Capecitabine—colon cancer	0.00703	0.00719	CcSEcCtD
Vilazodone—Flatulence—Capecitabine—colon cancer	0.00693	0.00708	CcSEcCtD
Vilazodone—Erectile dysfunction—Methotrexate—colon cancer	0.00692	0.00707	CcSEcCtD
Vilazodone—Dysgeusia—Capecitabine—colon cancer	0.00688	0.00704	CcSEcCtD
Vilazodone—Feeling abnormal—Fluorouracil—colon cancer	0.00676	0.00692	CcSEcCtD
Vilazodone—Vision blurred—Capecitabine—colon cancer	0.00662	0.00678	CcSEcCtD
Vilazodone—Tremor—Capecitabine—colon cancer	0.00659	0.00674	CcSEcCtD
Vilazodone—Asthenia—Vincristine—colon cancer	0.00631	0.00646	CcSEcCtD
Vilazodone—Palpitations—Capecitabine—colon cancer	0.00621	0.00635	CcSEcCtD
Vilazodone—Asthenia—Irinotecan—colon cancer	0.00615	0.00629	CcSEcCtD
Vilazodone—Diarrhoea—Vincristine—colon cancer	0.00602	0.00616	CcSEcCtD
Vilazodone—Arthralgia—Capecitabine—colon cancer	0.00598	0.00612	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00594	0.00608	CcSEcCtD
Vilazodone—Diarrhoea—Irinotecan—colon cancer	0.00586	0.006	CcSEcCtD
Vilazodone—Dry mouth—Capecitabine—colon cancer	0.00585	0.00599	CcSEcCtD
Vilazodone—Dizziness—Vincristine—colon cancer	0.00582	0.00595	CcSEcCtD
Vilazodone—Dizziness—Irinotecan—colon cancer	0.00567	0.0058	CcSEcCtD
Vilazodone—Nervous system disorder—Capecitabine—colon cancer	0.00563	0.00575	CcSEcCtD
Vilazodone—Eye disorder—Methotrexate—colon cancer	0.00562	0.00575	CcSEcCtD
Vilazodone—Diarrhoea—Fluorouracil—colon cancer	0.00562	0.00575	CcSEcCtD
Vilazodone—Vomiting—Vincristine—colon cancer	0.0056	0.00572	CcSEcCtD
Vilazodone—Cardiac disorder—Methotrexate—colon cancer	0.00558	0.00571	CcSEcCtD
Vilazodone—Skin disorder—Capecitabine—colon cancer	0.00557	0.0057	CcSEcCtD
Vilazodone—Hyperhidrosis—Capecitabine—colon cancer	0.00555	0.00567	CcSEcCtD
Vilazodone—Vomiting—Irinotecan—colon cancer	0.00545	0.00557	CcSEcCtD
Vilazodone—Dizziness—Fluorouracil—colon cancer	0.00543	0.00555	CcSEcCtD
Vilazodone—Mental disorder—Methotrexate—colon cancer	0.00527	0.00539	CcSEcCtD
Vilazodone—Malnutrition—Methotrexate—colon cancer	0.00523	0.00535	CcSEcCtD
Vilazodone—Nausea—Vincristine—colon cancer	0.00523	0.00535	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00523	0.00535	CcSEcCtD
Vilazodone—Vomiting—Fluorouracil—colon cancer	0.00522	0.00534	CcSEcCtD
Vilazodone—Insomnia—Capecitabine—colon cancer	0.00519	0.00531	CcSEcCtD
Vilazodone—Paraesthesia—Capecitabine—colon cancer	0.00515	0.00527	CcSEcCtD
Vilazodone—Dysgeusia—Methotrexate—colon cancer	0.00512	0.00524	CcSEcCtD
Vilazodone—Nausea—Irinotecan—colon cancer	0.00509	0.00521	CcSEcCtD
Vilazodone—Dyspepsia—Capecitabine—colon cancer	0.00505	0.00517	CcSEcCtD
Vilazodone—Decreased appetite—Capecitabine—colon cancer	0.00499	0.0051	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00495	0.00507	CcSEcCtD
Vilazodone—Fatigue—Capecitabine—colon cancer	0.00495	0.00506	CcSEcCtD
Vilazodone—Vision blurred—Methotrexate—colon cancer	0.00493	0.00504	CcSEcCtD
Vilazodone—Nausea—Fluorouracil—colon cancer	0.00488	0.00499	CcSEcCtD
Vilazodone—Feeling abnormal—Capecitabine—colon cancer	0.00473	0.00484	CcSEcCtD
Vilazodone—Convulsion—Methotrexate—colon cancer	0.00453	0.00464	CcSEcCtD
Vilazodone—Arthralgia—Methotrexate—colon cancer	0.00445	0.00456	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00442	0.00453	CcSEcCtD
Vilazodone—Nervous system disorder—Methotrexate—colon cancer	0.00419	0.00428	CcSEcCtD
Vilazodone—Skin disorder—Methotrexate—colon cancer	0.00415	0.00424	CcSEcCtD
Vilazodone—Hyperhidrosis—Methotrexate—colon cancer	0.00413	0.00422	CcSEcCtD
Vilazodone—Asthenia—Capecitabine—colon cancer	0.00412	0.00421	CcSEcCtD
Vilazodone—Diarrhoea—Capecitabine—colon cancer	0.00392	0.00401	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00389	0.00398	CcSEcCtD
Vilazodone—Insomnia—Methotrexate—colon cancer	0.00386	0.00395	CcSEcCtD
Vilazodone—Paraesthesia—Methotrexate—colon cancer	0.00383	0.00392	CcSEcCtD
Vilazodone—Somnolence—Methotrexate—colon cancer	0.0038	0.00388	CcSEcCtD
Vilazodone—Dizziness—Capecitabine—colon cancer	0.00379	0.00388	CcSEcCtD
Vilazodone—Dyspepsia—Methotrexate—colon cancer	0.00376	0.00385	CcSEcCtD
Vilazodone—Decreased appetite—Methotrexate—colon cancer	0.00371	0.0038	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methotrexate—colon cancer	0.00369	0.00377	CcSEcCtD
Vilazodone—Fatigue—Methotrexate—colon cancer	0.00368	0.00377	CcSEcCtD
Vilazodone—Vomiting—Capecitabine—colon cancer	0.00365	0.00373	CcSEcCtD
Vilazodone—Feeling abnormal—Methotrexate—colon cancer	0.00352	0.0036	CcSEcCtD
Vilazodone—Nausea—Capecitabine—colon cancer	0.00341	0.00349	CcSEcCtD
Vilazodone—Asthenia—Methotrexate—colon cancer	0.00306	0.00313	CcSEcCtD
Vilazodone—Diarrhoea—Methotrexate—colon cancer	0.00292	0.00299	CcSEcCtD
Vilazodone—Dizziness—Methotrexate—colon cancer	0.00282	0.00289	CcSEcCtD
Vilazodone—Vomiting—Methotrexate—colon cancer	0.00272	0.00278	CcSEcCtD
Vilazodone—Nausea—Methotrexate—colon cancer	0.00254	0.00259	CcSEcCtD
